Operating Expenses Endring Dato
AbbVie USD 11.11B 540M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
AstraZeneca USD 9.54B 578M 2023-09
GlaxoSmithKline GBP 6.2B 1.16B 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09



Amarin Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.